Literature DB >> 31102034

Successful Rituximab Treatment for Lymphoma, Secondary Immunodeficiency Causing Debilitating Sinusitis: Underlying Primary Immunodeficiency Disease, and Alternative Treatments to Improve the Quality of Life?

Vincent R Bonagura1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31102034     DOI： 10.1007/s10875-019-00636-1

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN： 0271-9142            Impact factor:   8.317


× No keyword cloud information.
  4 in total

1.  Incidence of hypogammaglobulinemia in patients receiving rituximab and the use of intravenous immunoglobulin for recurrent infections.

Authors:  Carla Casulo; Jocelyn Maragulia; Andrew D Zelenetz
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2012-12-29

Review 2.  Secondary Hypogammaglobulinemia: An Increasingly Recognized Complication of Treatment with Immunomodulators and After Solid Organ Transplantation.

Authors:  Blanka Kaplan; Vincent R Bonagura
Journal:  Immunol Allergy Clin North Am       Date:  2019-02       Impact factor: 3.479

Review 3.  Rituximab and immune deficiency: case series and review of the literature.

Authors:  Blanka Kaplan; Yelena Kopyltsova; Amrita Khokhar; Fung Lam; Vincent Bonagura
Journal:  J Allergy Clin Immunol Pract       Date:  2014-08-07

4.  Human milk proresolving mediators stimulate resolution of acute inflammation.

Authors:  Hildur Arnardottir; Sarah K Orr; Jesmond Dalli; Charles N Serhan
Journal:  Mucosal Immunol       Date:  2015-10-14       Impact factor: 7.313
  4 in total
  1 in total

1.  Editorial, Journal of Clinical Immunology.

Authors:  Jean-Laurent Casanova; Vincent Bonagura
Journal:  J Clin Immunol       Date:  2019-11       Impact factor: 8.317
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.